KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours
Maria Dêbiec‐Rychter(KU Leuven), Raf Sciot(KU Leuven), Axel Le Cesne(Institut Gustave Roussy), M. Schlemmer(Institute of Groundwater Ecology), Peter Hohenberger(Charité - Universitätsmedizin Berlin), Allan T. van Oosterom(KU Leuven), Jean‐Yves Blay(Centre Léon Bérard), Serge Leyvraz(University Hospital of Lausanne), Michel Stul(KU Leuven), Paolo G. Casali(Fondazione IRCCS Istituto Nazionale dei Tumori), John Zalcberg(Peter MacCallum Cancer Centre), Jaap Verweij(Erasmus MC), M. van Glabbeke(European Organisation for Research and Treatment of Cancer), Anne Hagemeijer(KU Leuven), Ian Judson(Royal Marsden Hospital)
Cited by 898
Abstract
Related Papers
No related papers found
Powered by citation graph analysis